Model
Edge
EyePoint Pharmaceuticals Inc.
0001736240
Filing type
4/A
Filing date
Sep 5, 2023
Updated
Sep 6, 2023 ยท 1:10 PM
Copy reference
Filing
4/A
Amended Statement of Changes in Beneficial Ownership